Robert M. Jotte

1 ta ish

Texas Oncology

1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

   Mark A. Socinski, Robert M. Jotte, Federico Cappuzzo +17

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.586467